Quality Systems
Inc develops and markets healthcare information systems in the US ;
they include systems that automate medical and dental practices and networks of
practices such as physician hospital and management services organizations,
ambulatory care centers and medical and dental schools. In addition, QSII
offers proprietary electronic medical records under the NextGen product
name. Its products include electronic
health records, enterprise appointment scheduling, enterprise master patient
index, NextGen image control systems, managed care server, electronic data
interchange, system interfaces, Internet operability and patient-centric and
provider-centric Wed portal solutions, NextGen Express for small practices,
revenue cycle management services which include billing and collections
services. The company has grown profits and
dividends at a 10-15%+ rate over the past five years earning a 20%+ return on
equity.
The company witnessed
a slowdown in profit growth as ambiguity in the regulatory environment dampened
sales; however, as clarity is gained once the election is over, it should resume
growth at an above average pace as a result of:
(1) expansion of
its client base, its product offerings and the rising demand of its clients for
its expertise,
(2) strong
demand in its NextGen division,
(2) acquisitions.
Negatives:
(1) it is in a
highly competitive industry,
(2) its business
is overly concentrated in physician practice,
(3) weakness in
the software environment.
Statistical Summary
Stock Dividend Payout # Increases
Yield Growth Rate Ratio
Since 2005
Debt/ EPS Down Net Value Line
Equity ROE Since 2002 Margin Rating
* QSII
has only paid a dividend for 6 years
**most companies in QSII
industry do not pay dividends
Chart
Note:
QSII stock made good initial progress off
its December 2008 low, quickly surpassing the downtrend off its September 2008
high (straight red line) and the November 2008 trading high (green line). Long
term the stock is in a trading range (blue lines). As noted above, early this year, QSII
reported disappointed revenue and profit growth and the stock declined. The Aggressive Portfolio started to Sell its
position when it traded below its Stop Loss Price. Unfortunately, it Sold only one half before
the stock gapped down. At that point,
given its proximity to its Buy Value
Range , it made a small trading purchase. That has left the Portfolio with
approximately a one half position. The
upper boundary of its Buy Value
Range is $13. The lower boundary of its Sell
Half Range
is $90. The wiggly red line is the 50
day moving average.
10/12
No comments:
Post a Comment